ジャパンタイムズ8 天
AstraZeneca and Daiichi’s breast cancer drug gets EU backing
The treatment pairs a tumor-killing drug with an antibody designed to home in on cancerous tissue. In December, Astra and Daiichi withdrew an application in the EU for the drug to treat a type of ...
ジャパンタイムズ19 天
Daiichi Sankyo rises most in five months on cancer drug approval
The approval is the first in the United States for Datroway, which got clearance in Japan last month. AstraZeneca and Daiichi Sankyo withdrew an application in the European Union for the drug to ...
朝日新聞社4 年
Daiichi Sankyo’s U.S. breast cancer drug set for Japan release
Daiichi Sankyo Co. said during an April 27 conference call held to disclose its financial results it expects combined sales of its anti-cancer drug Enhertu in Japan and the United States to hit ...
来自MSN1 个月
Daiichi Sankyo gets Japanese approval for Datroway
Daiichi Sankyo (OTCPK:DSKYF) stock slid 10% Friday after the Japanese drugmaker announced it had received approval in Japan for its DXd antibody-drug conjugate Datroway for the treatment of HR+ ...